• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION(RIDGEFIELD) SYNVISC MOZ

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION(RIDGEFIELD) SYNVISC MOZ Back to Search Results
Lot Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Irritation (1941); Synovitis (2094); Hot Flashes/Flushes (2153); Myalgia (2238)
Event Date 03/21/1999
Event Type  Injury  
Event Description
Scratchy eyes [irritation of eyes], flushing [flushing], myalgias [myalgia], synovitis of (l) knee "joint results, and referenced here" biomatrix [synovitis of knee] ([product use in unapproved indication]). Case narrative: initial information received on 08-jan-2021 regarding an unsolicited valid serious case received from physician via health authorities of united states under reference mw5097842. This case involves adult patient of unknown gender who experienced scratchy eyes, flushing, myalgias and synovitis of (l) knee "joint results, and referenced here" biomatrix, while he/she was treated with medical device hylan g-f 20, sodium hyaluronate (synvisc). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included diclofenac (voltaren); and famotidine (pepcid 20 rnd) and vitamin on an unknown date, the patient started using intra-articular injection of hylan g-f 20, sodium hyaluronate (dose, frequency, lot - unknown) for serious injury (product use in unapproved indication). There will be no information available on the batch number for this case. On an unknown date, after unknown latency, patient had flushing, scratchy eyes (eye irritation), myalgias (myalgia) following injection of knees with hylan g-f 20, sodium hyaluronate. On (b)(6) 1999, after unknown latency, patient had synovitis of (l) knee "joint results and referenced here" biomatrix (synovitis). All events were assessed as serious as intervention was required. Action taken: unknown for all events. It was not reported if the patient received a corrective treatment. Outcome: unknown for all events. A product technical complaint (ptc) was initiated on 08-jan-2021 for synvisc one for unknown batch number and global ptc number: (b)(4). The product lot number was not provided; therefore, a batch record review was not possible. It was the requirement to review all finished batch records for specification conformance prior to release. Any out of specification result was identified and mitigated through the ncr (non-conformances report) process. Adverse event reports with or without lot numbers were continuously monitored, and possible associations with their corresponding product lot are assessed, as part of routine safety surveillance effort to detect safety signals. This review has not indicated any safety issue. Sanofi would continue to monitor adverse events to determine if a capa (corrective and preventive action) was required. Investigation completion date: 22-jan-2021. Follow up received on 08-jan-2021 from healthcare professional. Global ptc number added. Text amended accordingly. Additional information was received on 22-jan-2021 from healthcare professional. Investigational results were added. Text amended accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameSYNVISC
Type of DeviceMOZ
Manufacturer (Section D)
GENZYME CORPORATION(RIDGEFIELD)
1125 pleasantview terrace
ridgefield 07657
Manufacturer (Section G)
GENZYME CORPORATION(RIDGEFIELD)
1125 pleasantview terrace
ridgefield 07657
Manufacturer Contact
heather schiappacasse
55 corporate drive, ms 55b-220
a
bridgewater 08807
MDR Report Key11257832
MDR Text Key233159645
Report Number2246315-2021-00059
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial
Report Date 02/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/01/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Was the Report Sent to FDA?
Event Location No Information
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 02/01/2021 Patient Sequence Number: 1
-
-